Merck to present new and updated data of Keytruda to treat breast cancers at 2017 SABC symposium
Merck, known as MSD outside the United States and Canada, announced that new and updated data from six abstracts investigating...
Positive Preclinical Data from Xenon’s XEN901 Epilepsy Program to be Presented at the 71st American Epilepsy Society Annual Meeting
Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a clinical-stage biopharmaceutical company, today announced the presentation of a scientific poster entitled “Selective Inhibitors Suggest...
FDA Approves Amgen’s Repatha® (evolocumab) To Prevent Heart Attack And Stroke
Amgen announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved...
ViiV Healthcare begins phase III study of long-acting cabotegravir for HIV prevention in women
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced...
NIH initiates HIV prevention trial of long-acting injectable medication in sexually active women
The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The...
Portugal researcher to create 3D cancer disease models
The Institution of Engineering and Technology (IET) in the UK has awarded a prize fund to a Portuguese researcher for...
FDA grants orphan drug status to Shire’s UC treatment SHP647
The US Food and Drug Administration (FDA) has granted orphan drug designation to Shire’s investigational mucosal addressin cell adhesion molecule-1...
Cancer Genetics and ICON to reduce cancer mortality rate in India
US-based Cancer Genetics (CGI) has collaborated with the Indian Cooperative Oncology Network (ICON) to minimise cancer mortality rates by optimising...
NeuroVive’s genetic mitochondrial disease program NVP015 reaches significant milestone
NeuroVive Pharmaceutical AB, the mitochondrial medicine company, announced that molecules in its NVP015 program have demonstrated positive effects in experimental...
UCB showcases new research and continued epilepsy leadership at the 2017 American Epilepsy Society Annual Meeting
UCB is pleased to announce that 25 scientific abstracts have been accepted for poster presentation at the upcoming 71st American...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.